Fecal Occult Blood Screening for Colorectal Cancer: Is Mortality Reduced by Chance Selection for Screening Colonoscopy?

JAMA: The Journal of the American Medical Association

Volumn 271, Issue 13, 1994, Pages 1011-1013

  Lang, Christopher A ^a   Ransohoff, David F ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER MORTALITY; CANCER SCREENING; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL CANCER; HUMAN; MATHEMATICAL MODEL; OCCULT BLOOD TEST; PRIORITY JOURNAL; REHYDRATION;

EID: 84942481355     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1994.03510370063033     Document Type: Article

References (24)

1. National Cancer Institute. Working Guidelines for Early Cancer Detection: Rationale and Supporting Evidence to Decrease Mortality. Bethesda, Md: National Cancer Institute; 1987.
2. American Cancer Society. Summary of Current Guidelines for the Cancer-Related Check Up: Recommendations. New York, NY: American Cancer Society; 1989.
3. Knight KK, Fielding JE, Battista RN. Occult blood screening for colorectal cancer. JAMA. 1989; 261:586-593.
4. American College of Physicians, Clinical Efficacy Assessment Project. Screening for Colorectal Cancer. Philadelphia, Pa: American College of Physicians; 1990.
5. Levin B, Murphy GP. Revision in American Cancer Society recommendations for the early detection of colorectal cancer. CA Cancer J Clin. 1992; 42:296-299.
6. Clayman CB. Mass screening for colorectal cancer: Are we ready? JAMA. 1989;261:609.
7. Smart CR. Critique of the early cancer detection guidelines of the US Preventive Services Task Force and of the National Cancer Institute. Mayo Clin Proc. 1990;65:892-898.
8. Ransohoff DF, Lang CA. Screening for colorectal cancer. N Engl J Med. 1991;325:37-41.
9. Ransohoff DF, Lang CA. Sigmoidoscopic screening in the 1990s. JAMA. 1993;269:1278-1281.
10. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med. 1993;328:1365-1371.
11. The value of colon cancer tests. New York Times. May 21, 1993:A26. Editorial.
12. Winawer SJ. Colorectal cancer screening comes of age. N Engl J Med. 1993;328:1416-1417.
13. Kronborg O, Fenger C, Sondergaard O, Pedersen KM, Olsen J. Initial mass screening for colorectal cancer with fecal occult blood test. Scand J Gastroenterol. 1987;22:677-686.
14. KewenterJ, Bjork S, Haglind E, Smith L, Svanvik J, Ahren C. Screening and rescreening for colorectal cancer: A controlled trial of fecal occult blood testing in 27 700 subjects. Cancer. 1988;62:645-651.
15. Hardcastle JD, Thomas WM, Chamberlain J, et al. Randomised, controlled trial of fecal occult blood screening for colorectal cancer. Lancet. 1989;1:1160-1164.
16. Winawer SJ, Flehinger BJ, Schottenfeld D, Miller DG. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst. 1993;85:1311-1318.
17. Boland CR. State of the art lecture: Reducing colorectal cancer mortality: Screening, case findings, and surveillance. Presented at the Plenary Session of American Gastroenterological Association Meeting; May 17, 1993; Boston, Mass.
18. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst. 1992;84:1572-1575.
19. Selby JV, Friedman GD, Quesenberry CPJ, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326:653-657.
20. National Center for Health Statistics. Vital Statistics of the United States, 1989: Volume II, Section 6—Life Tables. Washington, DC: Public Health Service; 1992.
21. Miller BA, Ries LAG, Hankey BF, Kosary CL, Edwards BK. Cancer Statistics Review: 1973-1989. Bethesda, Md: National Cancer Institute; 1992. National Institutes of Health publication 92-2789.
22. Ahlquist DA, Wieand HS, Moertel CG, et al. Accuracy of fecal occult blood screening for colorectal neoplasia: A prospective study using Hemoccult and Hemo Quant tests. JAMA. 1993;269:1262-1267.
23. Ransohoff DF, Feinstein AR. Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N Engl J Med. 1978;299:926-930.
24. Ransohoff DF, Lang CA, Kuo HS. Colonoscopic surveillance after polypectomy: Considerations of cost-effectiveness. Ann Intern Med. 1991;114:177-182.